| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| hydroxyurea | ribonucleoside-diphosphate reductase large subunit | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Epithelial ovarian cancer[MeSHID:C538090] melanoma[MeSHID:D008545] Anemia Sickle Cell[MeSHID:D000755] Recurrence (disease attribute)[MeSHID:D012008] Myeloid Leukemia Chronic[MeSHID:D015464] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
2.6 | approved | inhibitor |
| hydroxyurea | ribonucleoside-diphosphate reductase m2 | NA | Successful target | TTD , DGIDB | Disease Management[MeSHID:D019468] Epithelial ovarian cancer[MeSHID:C538090] melanoma[MeSHID:D008545] Anemia Sickle Cell[MeSHID:D000755] Recurrence (disease attribute)[MeSHID:D012008] Myeloid Leukemia Chronic[MeSHID:D015464] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
1.05 | approved | unknown |
| hydroxyurea | ribonucleoside-diphosphate reductase m2 | NA | Successful target | TTD , DGIDB | Disease Management[MeSHID:D019468] Epithelial ovarian cancer[MeSHID:C538090] melanoma[MeSHID:D008545] Anemia Sickle Cell[MeSHID:D000755] Recurrence (disease attribute)[MeSHID:D012008] Myeloid Leukemia Chronic[MeSHID:D015464] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
1.05 | approved | inhibitor |
| click here to return to the previous page | ||||||||